| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07052630 Patient Navigation and the Planning Advance Care Together Website to Improve Goals of… |
date change Primary completion pushed: 2026-05-31 -> 2026-09-30 |
| 2026-06-06 | NCT07052630 Patient Navigation and the Planning Advance Care Together Website to Improve Goals of… |
date change Completion pushed: 2026-07-31 -> 2026-10-31 |
| 2026-06-05 | NCT06822530 A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With… |
date change Primary completion pushed: 2029-01-31 -> 2030-01-31 |
| 2026-06-05 | NCT06822530 A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With… |
date change Completion moved earlier: 2030-07-31 -> 2030-01-31 |
| 2026-06-05 | NCT04579523 ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and… |
date change Primary completion pushed: 2027-12-31 -> 2028-12-31 |
| 2026-06-05 | NCT04579523 ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and… |
date change Completion pushed: 2028-12-31 -> 2029-12-31 |
| 2026-06-05 | NCT07571018 A Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults |
Recruitment opened |
| 2026-05-23 | NCT06771739 A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial |
date change Primary completion pushed: 2026-06-30 -> 2026-12-01 |
| 2026-05-23 | NCT06771739 A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial |
date change Completion pushed: 2026-06-30 -> 2026-12-01 |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
Enrollment reduced: 20 -> 1 participants |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Primary completion moved earlier: 2027-12-31 -> 2026-01-23 |
| 2026-05-23 | NCT06752694 Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell… |
date change Completion moved earlier: 2027-12-31 -> 2026-10-15 |
| 2026-05-23 | NCT06909500 A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07615764 An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04265950 | Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents… | HIV Infection | Active, Not Recruiting |
| Phase 3 | |||
| NCT06811038 | iCanQuit Smoking Cessation Among Hispanic Adults | Cigarette Smoking-Related Carcinoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT04370301 | Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… | Primary Myelofibrosis | Recruiting |
| NCT06013423 | Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT06145633 | Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT07046078 | Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT07228624 | Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… | Myelodysplastic/Myeloproliferative Neoplasm | Recruiting |
| NCT03970096 | Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant… | Acute Leukemia | Recruiting |
| NCT03980769 | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating… | Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder | Recruiting |
| NCT07011810 | Axatilimab for Sclerotic Chronic Graft-versus-Host Disease | Chronic Graft Versus Host Disease | Recruiting |
| NCT07209371 | Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of… | IgA Monoclonal Gammopathy of Undetermined Significance | Recruiting |
| NCT05952804 | IVIG for Infection Prevention After CAR-T-Cell Therapy | Hematologic Malignancies | Recruiting |
| NCT06839053 | Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT03779854 | Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and… | Acute Biphenotypic Leukemia | Recruiting |
| NCT04941716 | Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent… | Recurrent Chronic Lymphocytic Leukemia | Recruiting |
| NCT04195633 | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… | Acute Leukemia | Recruiting |
| NCT06817889 | Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in… | Hematopoietic and Lymphatic System Neoplasm | Recruiting |
| NCT05996627 | Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host… | Chronic Graft Versus Host Disease | Recruiting |
| NCT07194980 | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory… | Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting |
| NCT04572815 | Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor… | Hematologic and Lymphocytic Disorder | Active, Not Recruiting |
| NCT06026371 | Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in… | Acute Graft Versus Host Disease | Active, Not Recruiting |
| NCT04994808 | Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT07390968 | Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult… | Hematopoietic and Lymphatic System Neoplasm | Not Yet Recruiting |
| NCT00716066 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | Autoimmune Disease | Active, Not Recruiting |
| NCT04384692 | Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis | Primary Myelofibrosis | Active, Not Recruiting |